TTGG Actively Supports the Development of Key Industries in Wuhan Optics Valley

TTGG invested in Cingular Biotechnology, China's Leading Innovative R&D Enterprise of Biological Prosthetic Heart Valves

TTGG: We Aim to Support Strong Industrial Chains, Strengthen Areas of Weakness in Chains, and Extend Chains to Promote the High-quality Development of the Real Economy.

Yongan Futures (600927), a Portfolio Company of TTGG, Has Set a Benchmark in the Futures Industry by Getting Listed on the Shanghai Stock Exchange.

TTGG Portfolio Company Estone was Honored as the "Golden Bull Best IPO Case" by China Securities Journal

Bio-Sincerity(301096), a Portfolio Company of TTGG, was Listed on the Growth Enterprise Market (GEM), Becoming a Benchmark for China's Comprehensive "Pharmaceuticals + Clinical" Integrated CRO Enterpr